We are live on ! Find out more
PCM

Patient Capital Management Portfolio holdings

AUM $2.74B
1-Year Est. Return 43.59%
This Fund
S&P 500
This Quarter Est. Return
-0.18%
1 Year Est. Return
+43.59%
3 Year Est. Return
+124.98%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$2.04B
AUM Growth
+$154M
Cap. Flow
+$200M
Cap. Flow %
9.8%
Top 10 Hldgs %
45.8%
Holding
42
New
2
Increased
10
Reduced
26
Closed
1

Top Buys

Rank Stock Value
1
QXO
QXO Inc
QXO
+$226M
2
PLAY icon
Dave & Buster's
PLAY
+$44.3M
3
RPRX icon
Royalty Pharma
RPRX
+$17.1M
4
SOFI icon
SoFi Technologies
SOFI
+$14.2M
5
SDRL icon
Seadrill
SDRL
+$5.43M

Top Sells

Rank Stock Value
1
JPM icon
JPMorgan Chase
JPM
+$26.7M
2
EVRI
Everi Holdings
EVRI
+$13M
3
WAL icon
Western Alliance Bancorporation
WAL
+$11.5M
4
FISV
Fiserv Inc
FISV
+$9.7M
5
EXPE icon
Expedia Group
EXPE
+$9.09M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 30.99%
2 Financials 16.16%
3 Communication Services 15.58%
4 Industrials 11.96%
5 Healthcare 11.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SDRL icon
26
Seadrill
SDRL
$2.72B
$40.8M 2%
1,025,645
+118,048
+13% +$5.43M
TNL icon
27
Travel + Leisure Co
TNL
$4.69B
$40.7M 2%
884,133
-15,742
-2% -$695K
KOS icon
28
Kosmos Energy
KOS
$1.52B
$38M 1.87%
9,440,022
+355,143
+4% +$1.73M
COIN icon
29
Coinbase
COIN
$40.1B
$31.5M 1.55%
176,832
-2,321
-1% -$465K
FISV
30
Fiserv Inc
FISV
$27.7B
$23.9M 1.17%
132,870
-58,820
-31% -$9.7M
PTON icon
31
Peloton Interactive
PTON
$2.43B
$23.7M 1.16%
5,055,332
-264,668
-5% -$1.04M
WAL icon
32
Western Alliance Bancorporation
WAL
$8.93B
$20.4M 1%
235,492
-149,255
-39% -$11.5M
EXE
33
Expand Energy Corp
EXE
$21.6B
$19.5M 0.96%
236,684
-6,553
-3% -$500K
PGEN icon
34
Precigen
PGEN
$2.57B
$17M 0.83%
17,937,694
-236,964
-1% -$299K
JPM icon
35
JPMorgan Chase
JPM
$951B
$6.2M 0.3%
29,386
-126,593
-81% -$26.7M
FBTC icon
36
Fidelity Wise Origin Bitcoin Fund
FBTC
$12B
$5.38M 0.26%
96,851
-5,986
-6% -$319K
EVRI
37
DELISTED
Everi Holdings
EVRI
$4.76M 0.23%
362,620
-1,100,633
-75% -$13M
LEN.B icon
38
Lennar Class B
LEN.B
$20.9B
$2.16M 0.11%
13,150
– –
TEVA icon
39
Teva Pharmaceuticals
TEVA
$40.9B
$1.8M 0.09%
100,000
– –
SPY icon
40
State Street SPDR S&P 500 ETF Trust
SPY
$822B
$852K 0.04%
1,486
+748
+101% +$414K
BRLT icon
41
Brilliant Earth
BRLT
$20.5M
$517K 0.03%
241,445
– –
UBER icon
42
Uber
UBER
$153B
– –
-26,183
Closed -$1.9M
1
2

Similar funds

CIAS
CBIZ Investment Advisory Services Independence, Ohio $2.74B AUM 14.19% 1-Year Est. Return
LMIM
Lockheed Martin Investment Management Bethesda, Maryland $2.73B AUM 28.24% 1-Year Est. Return
GC
Giverny Capital Montreal, Quebec, Canada $2.73B AUM 14.09% 1-Year Est. Return
CC
Cartenna Capital Stamford, Connecticut $2.74B AUM 44.46% 1-Year Est. Return
PA
Profund Advisors Bethesda, Maryland $2.72B AUM 47.27% 1-Year Est. Return
XL
XN LP New York $2.72B AUM 46.67% 1-Year Est. Return
SFFS
Stonehage Fleming Financial Services St. Helier, Jersey $2.75B AUM 13.81% 1-Year Est. Return
HRCM
Hawk Ridge Capital Management Los Angeles, California $2.75B AUM 20.09% 1-Year Est. Return

Patient Capital Management's Q3 2024 Portfolio in Review

As of Q3 2024, Patient Capital Management held 42 positions worth $2.04B, up 8.2% from $1.88B the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Patient Capital Management deployed $200M of net new capital in Q3 2024, opening 2 new positions and adding to 10 existing holdings. Its largest new stake was QXO Inc: 7,741,847 shares worth $122M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 31% of assets, down from 33% a quarter earlier, followed by Financials and Communication Services.

On the sell side, the largest reduction was JPMorgan Chase, an estimated $26.7M trimmed.

  • Patient Capital Management's largest Q3 2024 buy was QXO Inc: 7,741,847 shares worth $122M.
  • Patient Capital Management added most to Royalty Pharma in Q3 2024, an estimated $17.1M increase.
  • Patient Capital Management's biggest Q3 2024 reduction was JPMorgan Chase, cutting an estimated $26.7M.
  • Patient Capital Management fully exited Uber in Q3 2024, selling an estimated $1.9M.
  • Patient Capital Management's ten largest holdings make up 46% of its $2.04B portfolio in Q3 2024.
  • Patient Capital Management opened 2 new positions and closed 1 in Q3 2024.
  • Patient Capital Management's portfolio value rose 8.2% quarter-over-quarter to $2.04B.

Based on Patient Capital Management's 13F filing for Q3 2024, filed 14 Nov 2024.